European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting

• Date:
  Tuesday, 19 September 2023
• Location:
  Online
  European Medicines Agency, Amsterdam, the Netherlands

The Patients and Consumers' Working Party (PCWP) and the Healthcare Professionals' Working Party (HCPWP) will hold their joint plenary meeting on 19-20 September 2023.

Topics on first half-day of the virtual meeting will include the involvement of patient and HCP representatives in various EMA working groups, updates on crisis preparedness, big data, medicine shortages, and patient information.

During the second half-day, the working parties will discuss clinical trials and EMA communications, with updates from recent international activities.

Video recordings

1.1. Emergency Task Force (ETF)

1.2 HМА/EMA Joint Big Data Steering Group (BDSG)

1.3. Medicines Shortages Steering Group (MSSG)

2.1. Clinical trials in emergency situations

3.1. Big Data Steering Group updates

4.1. Results from surveys on medicine shortages

4.2. EU list of critical medicines

4.3. Update on preparedness activities

5.1. 'Communication of anticancer drug benefits and related uncertainties to patients and clinicians'

5.2. Revision of QRD template for package leaflet (PL) improvement

6.1. ICH E21 Concept paper on inclusion of pregnant and breastfeeding individuals in clinical trials

6.2: ACT EU Multi-stakeholder platform (MSP) advisory group update

7.1. Social media strategy

7.2. Mis- and disinformation

Documents

Agenda - PCWP/HCPWP joint meeting (19-20 September 2023)

DraftReference Number: EMA/901780/2022

Meeting summary - PCWP/HCPWP joint meeting (19-20 September 2023)

Reference Number: EMA/89221/2023

Presentation - Emergency Task Force (ETF) update - A. Simonds (ERS) and J. Drabwell (IPOPI)

Presentation - Medicines Shortages Steering Group (MSSG) - C. Roffiaen (EPHA) and P. Polidori (EAHP)

Presentation - Role of EMA in facilitating Clinical Trials in emergencies - M. Mura (EMA)

Presentation - Big Data Steering Group update - D. Umuhire (EMA)

Presentation - Feedback from surveys on medicine shortages - I. Abed (EMA) and S. Marschler (EMA)

Presentation - EU list of Critical Medicines - J. Ferreira (EMA)

Presentation - Update on preparedness activities - E. Matelyte (EMA)

Presentation - An analysis of regulated medicines information for cancer patients - C. Davis (Health Action International)

Presentation - QRD Template revision for package leaflet improvement - M. Buch (EMA)

Presentation - ICH E21: inclusion of pregnant & breastfeeding individuals in clinical trials - C. de Vries (EMA)

Presentation - Proposal for ACT EU MSP Advisory Group - A. Zanoletty (EMA) and M. Filancia (EMA)

Presentation - EMA Social Media Strategy 2023-2025 - C. Enachioiu (EMA)

Presentation - Addressing mis- and disinformation - S. Labbé (EMA)